Jeffrey Moore
InvestorPresident at MC Healthcare Ventures
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Dr. Jeff Moore joined MPH in 2008 with experience as a scientist, businessman, and investor, specializing in biochemistry, infectious disease, and immunology. He works closely with the firm's early-stage portfolio companies including F-star, Forge, and QurAlis.
Contact· self-published, not guessed
Experience
- MP Healthcare Venture ManagementPresident & Board Member2008 — 2026Boston, Massachusetts, United States
- TRIMTECH Therapeutics LimitedBoard Member2026Cambridge, England, United Kingdom
- PharmEnableBoard Member2022 — 2026Cambridge, England, United Kingdom
- Outrun TherapeuticsBoard Member2021 — 2026
- Blacksmith MedicinesBoard Observer2021 — 2026
- CapsigenBoard Member2020 — 2026
- Ribometrix Inc.Board Observer2020 — 2026
- Sonde Health, Inc.Board Observer2020 — 2026
- Forge Therapeutics, Inc.Board Observer2017 — 2026
- Diamond Edge VenturesBoard Member2018 — 2025Menlo Park, CA
- SOLA BiosciencesBoard Member2021 — 2024Natick, Massachusetts, United States
- Korro Bio, Inc.Board Observer2020 — 2023
- F-star Therapeutics, Inc.Board Observer2009 — 2020
- QurAlisBoard Member2018 — 2020Cambridge, MA
- Thrasos Innovation Inc.Board Observer2012 — 2018
- Rigontec GmbHBoard Observer2015 — 2017
- miRagen Therapeutics, Inc.Board Observer2015 — 2017
- GenoceaBoard Observer2010 — 2014
- Intradigm CorporationBoard Observer2008 — 2010
- Covagen AGBoard Observer2009
- Research Corporation TechnologiesAssociate / Kauffman Fellow2005 — 2007
- Research Corporation TechnologiesVenture Capitalist2005 — 2007
- Kauffman Fellows ProgramKauffman Fellow2005 — 2007
- MPM CapitalVenture Capital Intern2004
- Millennium PharmaceuticalsAssociate Director1999 — 2003
- BioVenture Investment Group (BVIG)Co-Founder and Treasurer1997 — 2001
- Scriptgen Pharmaceuticals (now Anadys)Research Fellow1997 — 1999
- Harvard Medical SchoolPostdoctoral Research Fellow1994 — 1997
- VirogeneticsPhD student1986 — 1990
Skills & more
FrenchEnglishSpanishSandConferencesPublic SpeakingWorkload PrioritizationStrategy9Strategic Planning4Target IdentificationEarly Stage InvestmentInvestment Decisions
+12 more
Reporting & AnalysisMilestonesGuitar PlayingMarketing ScienceProposal EvaluationDue DiligencePortfolio ManagementNASDAQStaff DevelopmentMedical DiagnosticsThird-Party Logistics (3PL)Investment StrategiesLanguages French · Spanish
From Jeffrey's professional profile.
Colleagues at MC Healthcare Ventures
Frequently asked questions
- Who is Jeffrey Moore?
- Dr. Jeff Moore joined MPH in 2008 with experience as a scientist, businessman, and investor, specializing in biochemistry, infectious disease, and immunology. He works closely with the firm's early-stage portfolio companies including F-star, Forge, and QurAlis.
- Where does Jeffrey Moore work?
- Jeffrey Moore is President at MC Healthcare Ventures.
- What check size does Jeffrey Moore write?
- Jeffrey Moore typically writes checks of $100K – $5M.
- Where did Jeffrey Moore go to school?
- Jeffrey Moore studied at MIT Sloan School of Management (MBA - Sloan Fellow, Finance & Entrepreneurship); University of Oxford (DPhil, Virology); Marine Biological Laboratory (Biology of Parasitism Summer Course).
Same school
Also attended MIT Sloan School of Management628
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor
+ 622 more
Shared employers
Also worked at TRIMTECH Therapeutics Limited6
Damian Crowtherex-AstraZeneca at PICUS CAPITALMichael AnsteyPartner at Cambridge Innovation CapitalHakan GokerManaging Director at M VenturesGeorgia FrostSenior Associate at Dementia DiscoveryGeorgia FrostVice President at Dementia Discovery FundMarie-Claire PeakmanExecutive Director, WWBD / Partner at Pfizer Venture Investments
